 |
|
|
| |
No Clinically Meaningful Pharmacokinetic Interactions Between HCV Inhibitors Grazoprevir/Elbasvir With Tacrolimus, Mycophenolate Mofetil, and Prednisone, But Cyclosporine Increases Grazoprevir/Elbasvir Exposures in Healthy Subjects
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Wendy W. Yeh1; Hwa-Ping Feng1; Katherine M. Dunnington2; Nadia Cardillo Marricco2; Luzelena Caro1; Zifang Guo1; Jennifer Talaty1; Dennis Wolford1; Michael Gartner2; Dennis Swearingen2; John Brejda2; Angela Choi2; William L. Marshall1; Marian Iwamoto1; Joan R. Butterton1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA
AASLD: Merck at AASLD / HepDart 2015 - (01/14/16)
|
| |
|
|
|
|
|
